There is a number in THREE International's 2023 epigenetic study that I have thought about almost every day since I first read it.
1,250%.
That is how much Éternel suppressed the IL-6 inflammatory gene in THLE-2 human liver cells using qRT-PCR gene expression methodology. It was the single strongest result across every product and every gene tested in the entire study. And it addresses the most important mechanism in cellular aging that most people — and most supplement companies — have never heard of.
I am a 68-year-old Maryland State Certified Residential Appraiser. License number 30004874. I spent 35 years identifying the difference between what something claims to be worth and what it actually is. I became a THREE International Founding Member after 2 months of independent research. I have taken Éternel daily for 3 years. This review is the complete case for why.
Section 1: The Real Mechanism Behind Cellular Aging
Most people understand aging as a visual and physical process — the lines, the energy decline, the slower recovery. What most people don't understand is the molecular mechanism producing those visible effects. And understanding that mechanism is necessary to evaluate whether any supplement can genuinely address it.
Inflammation as the Engine of Cellular Aging
The leading current model in aging research — supported by decades of peer-reviewed evidence — is that chronic, low-grade inflammation is the primary driver of accelerated cellular aging. Not inflammation in the acute, injury-response sense. Chronic systemic inflammation: a persistent, low-level activation of the inflammatory cascade that operates largely below the threshold of symptoms but produces continuous damage to cellular structures, DNA, and tissue function over years and decades.
The term researchers use for this is inflammaging — the convergence of inflammation and aging as interconnected biological processes rather than separate phenomena. It is supported by epidemiological data showing that elevated inflammatory markers in middle age are among the strongest predictors of cardiovascular disease, neurodegenerative conditions, metabolic dysfunction, and all-cause mortality in later life.
IL-6: The Inflammatory Marker of Cellular Age
Of all the molecular markers of chronic inflammation, IL-6 (interleukin-6) is among the most studied and most clinically significant. IL-6 is a cytokine — a signaling protein secreted by immune cells, fat tissue, and other cell types — that orchestrates the inflammatory cascade. When IL-6 is chronically elevated, it activates the nfkb inflammatory pathway, promotes the release of additional pro-inflammatory compounds, and initiates a self-reinforcing cycle of cellular damage and inflammatory response.
IL-6 levels are directly measurable in blood. Research consistently shows that adults with chronically elevated IL-6 have faster rates of telomere shortening, accelerated decline in cognitive function, greater cardiovascular disease risk, and shorter lifespan. It is one of the most direct molecular links between the state of chronic inflammation and the pace of biological aging.
This is why THREE's IL-6 result for Éternel — 1,250% suppression in the epigenetic study — is not just the most significant number in their research program. It is one of the most significant numbers I have encountered in reviewing any nutritional supplement's clinical data.
Section 2: The Resveratrol Problem — Why $600 of Supplements Did Nothing
Before I found THREE, I want to tell you what I was doing for three years. I was spending approximately $50 per month on a premium resveratrol supplement from a well-reviewed brand. It was clean, well-sourced, and cited the Harvard longevity research. I took it consistently. I felt nothing measurable.
In 2023, I read a paper that explained exactly why.
The First-Pass Metabolism Problem
In 2011, T. Walle published "Bioavailability of Resveratrol" in the Annals of the New York Academy of Sciences. The paper documents what researchers had been observing for years: resveratrol undergoes extensive first-pass metabolism in the gut and liver before reaching systemic circulation.
First-pass metabolism is a pharmacological term for what happens when a substance absorbed from the GI tract enters the portal circulation and passes through the liver before reaching systemic blood flow. The liver metabolizes many compounds aggressively during this first pass, converting them to forms that have different — often reduced — biological activity. For resveratrol, this process is particularly pronounced. Multiple studies have shown that oral resveratrol has poor absolute bioavailability; the compounds that survive to reach systemic circulation represent a small fraction of the ingested dose.
Trans-resveratrol undergoes rapid and extensive metabolism following oral ingestion, with extensive first-pass hepatic and intestinal metabolism severely limiting systemic bioavailability. The resulting plasma concentrations are typically far below those used in in-vitro studies showing biological effects.
Why the Supplement Industry Ignored This
The resveratrol bioavailability problem has been documented in the peer-reviewed literature since the early 2000s. The supplement industry largely ignored it — not necessarily out of deception, but because solving it requires sophisticated formulation chemistry that most manufacturers are not equipped to perform and that adds significant cost to production.
The result: tens of millions of people have spent billions of dollars on resveratrol supplements that deliver compounds their bodies cannot absorb efficiently. The ingredient research was promising. The delivery technology to make it clinically meaningful was absent in almost every commercial product.
I was one of those people. Three years and approximately $1,800. The concept was right. The delivery was wrong.
"Three years taking premium resveratrol. After reading Walle's 2011 paper alongside THREE's Caco-2 data, the reason it never worked became clear. The ingredient was right. The delivery was the problem. That's the kind of finding a 35-year appraiser does not walk past."
— Ed Drost, Maryland Certified Appraiser #30004874 · THREE International Founding MemberSection 3: Micro-Active Technology — How THREE Solved the Resveratrol Problem
THREE International's Micro-Active technology is a particle-size reduction process applied to trans-resveratrol. The principle: if large resveratrol molecules are metabolized before reaching systemic circulation, engineering molecules small enough to cross the intestinal membrane before the hepatic first-pass cycle can eliminate them changes the bioavailability equation fundamentally.
The Particle-Size Reduction Approach
Particle-size reduction is an established pharmaceutical technique. Drug manufacturers have used nanomilling and micro-particle engineering to improve the bioavailability of poorly soluble drugs for decades. The approach leverages the principle that smaller particles have greater surface area relative to their mass, resulting in faster dissolution rates and improved membrane permeability.
THREE's Micro-Active technology applies this principle specifically to resveratrol — engineering the trans-resveratrol in Éternel to particle sizes that facilitate rapid dissolution and efficient cellular uptake before the hepatic first-pass process has time to metabolize a significant portion of the dose.
The Caco-2 Validation
THREE commissioned a Caco-2 permeability assay conducted by Dr. Brett Stephens, Ph.D. at Wasatch Scientific Laboratories in collaboration with Dr. Dan Gubler, Ph.D. The Caco-2 assay uses human intestinal epithelial cells to measure the apparent permeability coefficient — the precise percentage of a substance crossing from the intestinal lumen side to the bloodstream side of the membrane. It is the gold-standard pharmaceutical pre-clinical bioavailability test.
Caco-2 Assay
vs. Standard Control
The control — standard curcumin, a well-studied organic molecule with no delivery technology — achieved 10%. Éternel achieved 95%. That 9.5× difference is not a marketing claim. It is a laboratory measurement validated by the same methodology pharmaceutical companies use to evaluate drug candidates before investing in clinical trials.
Of all products in the THREE line, Éternel has the highest cellular absorption percentage — higher than Purifí (88%), Collagène (73%), Vitalité (44%), and Revíve (30%). This is consistent with the Micro-Active particle-size reduction producing measurably superior membrane permeability compared to other delivery technologies.
Section 4: THREE Éternel Ingredients Explained
THREE Éternel is delivered as a daily liquid gel packet — 30 per box. The liquid format is itself a delivery advantage: liquid compounds begin dissolving immediately upon ingestion, ahead of the first-pass metabolism window, compared to capsules or tablets that require GI breakdown before the active ingredients are even in solution.
The formula contains five primary ingredient categories, each selected for a specific mechanism of action against oxidative stress and cellular aging:
Clean Label: What Éternel Does NOT Contain
THREE Éternel contains no artificial ingredients, colors, flavors, additives, gluten, casein, wheat, dairy, soy, corn, nuts, oats, TiO2 (titanium dioxide — a common tablet whitener with emerging safety concerns), lubricants, binders, or fillers. This matters both for safety and for bioavailability: every additive-free gram of Éternel's liquid gel content is biologically active compound, not filler.
Section 5: The IL-6 Epigenetic Data — What 1,250% Means for Cellular Aging
THREE International's 2023 epigenetic gene expression study was conducted by Paul Davis, Ph.D. and Catherine Davis, Ph.D. at Trinity Bioactives Ltd, in collaboration with Dr. Dan Gubler. The methodology used THLE-2 human liver cells — an immortalized line of normal human liver cells widely used in hepatotoxicity and gene expression research — with quantitative reverse transcription polymerase chain reaction (qRT-PCR). This is a well-established, peer-reviewed methodology for measuring gene expression changes at the mRNA level.
How THREE Éternel Suppresses the IL-6 Gene by 1,250%
The 1,250% IL-6 suppression in Éternel's epigenetic results represents a 12.5-fold reduction in IL-6 gene expression compared to the untreated control in THLE-2 cells. The mechanism operates through multiple pathways:
Resveratrol and NF-κB: Trans-resveratrol has documented ability to inhibit NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) — the transcription factor that activates IL-6 gene expression. By inhibiting NF-κB, resveratrol reduces the upstream signal that drives IL-6 production. At the 9.5× absorption advantage Éternel delivers, this inhibitory effect operates at intracellular concentrations that standard resveratrol supplements cannot achieve.
Polyphenol anti-inflammatory activity: The 10-superfruit polyphenol blend provides additional NF-κB inhibitory activity through multiple phytochemical pathways. Pomegranate punicalagins, mangosteen xanthones, and açai anthocyanins each have independent peer-reviewed evidence for anti-inflammatory gene expression modulation.
Glutathione oxidative stress reduction: Oxidative stress is a primary activator of the IL-6 inflammatory cascade. By directly neutralizing free radicals through glutathione activity, Éternel reduces the oxidative stress signal that would otherwise trigger IL-6 gene expression — a complementary anti-inflammatory mechanism acting upstream of the gene expression level.
The Full Epigenetic Profile for THREE Éternel
Source: Paul Davis PhD & Catherine Davis PhD, Trinity Bioactives Ltd, 2023. THLE-2 human liver cells, qRT-PCR methodology. In-vitro results — do not guarantee identical outcomes in human subjects.
Every result moves in the direction associated with improved cellular health: the two inflammatory genes (il-6, nfkb) are suppressed; the energy and antioxidant genes (ppara, sod1) are upregulated. The combination of maximum inflammatory suppression and simultaneous antioxidant and energy support in a single product is what makes Éternel's epigenetic profile uniquely comprehensive.
In-vitro disclosure: These results were obtained in THLE-2 human liver cell culture. They establish directionally meaningful gene expression signals that are consistent with Éternel's ingredient mechanisms and peer-reviewed research. They do not guarantee identical outcomes in live human subjects. No human clinical trial for Éternel's epigenetic effects has been published.
Section 6: SIRT1 — The Longevity Pathway Resveratrol Was Always Supposed to Reach
The scientific case for resveratrol was built primarily on SIRT1. Understanding why Éternel's Micro-Active technology matters requires understanding this connection.
What Is SIRT1 and Why Does It Matter?
SIRT1 (sirtuin-1) is a protein deacetylase — an enzyme that modifies proteins by removing acetyl groups, altering their function. It is involved in a remarkable range of aging-relevant biological processes: cellular stress response, DNA repair, mitochondrial biogenesis, glucose regulation, fat metabolism, and the regulation of the biological clock.
SIRT1 is often described as a "longevity gene" because its expression and activity are associated with lifespan extension in multiple organisms, and its activation mimics some of the effects of caloric restriction — one of the most consistently replicated longevity interventions in biology.
Harvard longevity researcher David Sinclair has spent decades documenting the relationship between NAD+, SIRT1, and aging. His work established resveratrol as a candidate SIRT1 activator and helped drive billions in research investment in this pathway.
The Concentration Problem That First-Pass Metabolism Creates
For resveratrol to activate SIRT1, it must reach sufficient intracellular concentration. In-vitro studies demonstrating SIRT1 activation have used resveratrol at concentrations that are achievable at the cellular level when delivery is controlled — concentrations that standard oral supplementation, given first-pass metabolism, cannot reliably achieve in human tissue.
Resveratrol supplementation improved mitochondrial function and metabolic factors in obese men. Authors attributed these effects to SIRT1 activation and downstream effects on mitochondrial biogenesis through the SIRT1-PGC-1α axis.
The Timmers et al. study is notable because it used relatively high-dose resveratrol (150mg daily) and found metabolic effects consistent with SIRT1 activation in human subjects — suggesting that when sufficient concentrations are achieved, the mechanism is real. The challenge for standard resveratrol supplements is achieving those concentrations given first-pass metabolism.
Éternel's Micro-Active technology — delivering 200mg trans-resveratrol at 95% cellular absorption — is specifically designed to close this gap. The particle-size reduction improves membrane permeability before hepatic first-pass metabolism, enabling the intracellular concentrations that SIRT1 activation requires.
Section 7: Real-World Benefits for Adults Over 50
The clinical data establishes the mechanism. What does it translate to in daily life for a professional in their 50s or 60s?
Reducing the Inflammation Driving Visible Aging
The visible markers of aging — skin laxity, reduced energy, slower recovery — are lagging indicators of a cellular aging process that has been building for years. The primary driver of that process, as the inflammatory aging research establishes, is chronic IL-6-mediated inflammation. Éternel's 1,250% IL-6 suppression — consistent with the known anti-inflammatory mechanisms of its key ingredients — directly targets this upstream driver.
This is meaningfully different from topical anti-aging products that address surface symptoms. Cellular anti-aging that operates at the gene expression level is intervening in the cause, not the appearance. The difference between painting over rust and treating the rust is an analogy my appraisal background makes obvious.
Addressing the Energy Variability of Aging Mitochondria
The ppara gene upregulation of 380% in Éternel's epigenetic data represents gene-level support for ATP energy production. CoQ10's mitochondrial electron transport chain role addresses the same problem through a different mechanism. Together, these compounds support the cellular energy infrastructure whose decline produces the unpredictable, inconsistent energy pattern that many adults over 50 have normalized as their baseline.
The distinction between stimulant-based energy (caffeine overriding adenosine signaling) and cellular energy support (CoQ10 and ppara supporting ATP synthesis) is important: stimulants borrow from tomorrow; cellular energy support improves the underlying system. Éternel is the latter.
Antioxidant Defense as a Cellular Investment
Oxidative stress accumulates with every decade of life. Environmental exposure — air pollution, processed food, UV radiation, medication — adds to the load that the body's endogenous antioxidant systems must manage. Glutathione is the primary defense. CoQ10 and the superfruit polyphenols provide complementary antioxidant activity through different pathways.
For adults over 50, this is not supplementation for marginal benefit. It is addressing the documented, measurable decline in endogenous antioxidant capacity that directly accelerates cellular aging when left unaddressed.
UV Protection at the Cellular Level
THREE documents UV shielding as one of Éternel's core benefits. The 10-superfruit polyphenol blend provides plant-based phytonutrients — particularly carotenoids and anthocyanins — that support the body's internal response to UV-induced oxidative stress. This is not sunscreen. It is nutritional support for the cellular repair mechanisms that respond to UV damage, relevant to anyone spending time outdoors or working in high-sun environments.
Section 8: My Personal Review — 3 Years of Daily Use at 68
I am a compensated THREE International Founding Member and Brand Ambassador. I disclose this on every page I publish, in every article I write, and at the top of this review. What follows is my personal experience, reported honestly.
Why I Started
I started taking Éternel not because someone recommended it but because the data told me to. After reading Walle's 2011 paper on resveratrol bioavailability and then encountering THREE's Caco-2 result, the mathematics were unambiguous. I had been taking standard resveratrol at approximately 10% absorption for three years. Éternel offered the same ingredient at 95% absorption. The difference wasn't theoretical.
I began taking it 6 months before I agreed to become a THREE ambassador. I wanted personal experience with the product before I put my professional reputation behind it. At 68, managing a licensed appraisal practice under Maryland's regulatory requirements, I do not endorse things I have not personally validated.
What Changed
Within the first 6 weeks, I noticed more consistent energy across the day. Not higher energy at any given moment — more even energy. The variability that had become my normal — good Tuesdays and foggy Thursdays with no clear pattern — became less pronounced. The floor of my daily function went up. By month 3, recovery from physical exertion — site visits, yard work, extended walking — was noticeably faster. By month 6, the results were consistent enough that I agreed to become a THREE Founding Member and attend the Salt Lake City launch convention.
Three years later, Éternel and Vitalité are the two products in my daily protocol I have never missed. That is not a marketing statement. It is a behavioral data point. When something stops working, you stop taking it. Three years of consistency is its own kind of evidence.
What I Cannot Claim
I cannot claim causation. I changed multiple things in my wellness protocol over the same period. I cannot produce a controlled clinical trial from my personal experience. What I can say is that my experience is directionally consistent with what the absorption data, the epigenetic data, and the peer-reviewed research on Éternel's ingredients would collectively predict. An appraiser's job is to weigh evidence. The evidence, in my case, has been consistent for 3 years.
Section 9: THREE Éternel vs. Standard Resveratrol Supplements
This is the comparison that matters most for anyone who has already tried resveratrol and been disappointed.
| Feature | THREE Éternel | Standard Resveratrol Supplement |
|---|---|---|
| Cellular absorption | 95% · 9.5× — Caco-2 validated | ~10% — first-pass limited |
| Delivery technology | Micro-Active particle-size reduction | Standard encapsulation — no delivery tech |
| First-pass metabolism addressed | Yes — core design objective | No — documented limitation ignored |
| Resveratrol form | Trans-resveratrol — bioactive form | Varies — not always specified |
| Additional antioxidants | Glutathione + CoQ10 + 10 superfruits | Resveratrol only in most products |
| Mitochondrial support | CoQ10 — RCT-validated (Mortensen 2014) | None in standard products |
| Epigenetic data | IL-6 −1,250% · nfkb −345% · ppara +380% | No test conducted |
| Format | Liquid gel packet — faster uptake | Capsule or tablet — slower dissolution |
| SIRT1 pathway viability | High — 9.5× absorption enables clinical concentrations | Low — first-pass limits intracellular levels |
| Artificial ingredients | None | Varies — fillers common |
| PDR recognition | Yes — THREE line listed | No |
The comparison is decisive. What standard resveratrol supplements have going for them is price and availability. Éternel competes on an entirely different dimension: the delivery technology that makes the resveratrol concept actually work at the cellular level it was always supposed to reach.
Purchase THREE Éternel (30 liquid gel packets) through Ed's ambassador account:
Purchase Éternel — 30-Day Supply →Interested in the THREE International ambassador opportunity? See how Ed built a wellness authority platform around science-verified products.
Explore the Opportunity →Section 10: Frequently Asked Questions
Section 11: Final Verdict
After 3 years of daily use, thorough review of THREE's clinical data, and independent research into the peer-reviewed literature on resveratrol bioavailability, IL-6 biology, mitochondrial aging, and glutathione depletion, I offer the following assessment:
THREE Éternel is the most sophisticated antioxidant delivery product I have reviewed. The 95% Caco-2 absorption result is the highest of any THREE product and directly addresses a documented scientific problem that the resveratrol supplement industry has largely ignored for 15 years. The 1,250% IL-6 suppression is the single strongest data point in THREE's entire clinical research program and addresses the primary molecular driver of cellular aging. At 68, running multiple enterprises and maintaining the professional standards a licensed appraisal practice demands, Éternel is one of the two supplements I have not missed a single day of in 3 years. The data and the experience point the same direction.
Who Éternel Is Best For
- Adults over 45 who have tried standard resveratrol supplements and felt nothing — the first-pass metabolism problem is almost certainly why
- Professionals concerned about the pace of cellular aging and looking for interventions with documented gene expression data behind them
- Anyone with inconsistent daily energy who wants cellular-level mitochondrial support rather than stimulant-based energy management
- Adults aware of the chronic inflammation-aging connection who want the most validated nutritional approach to IL-6 modulation available
- Anyone building a comprehensive THREE protocol — Éternel pairs naturally with Vitalité (foundational daily nutrition) as the core two-product stack
Who Should Consider Alternatives
- Anyone seeking the lowest-cost antioxidant option — Éternel's premium pricing reflects its delivery technology; standard resveratrol is cheaper
- Anyone with specific prescription drug interactions who should consult their physician before adding any supplement
- Anyone expecting rapid visible changes — the cellular anti-aging mechanisms Éternel addresses operate over weeks and months, not days
Ready to start? Purchase THREE Éternel through Ed's ambassador account — 30 liquid gel packets, ships directly from THREE International:
Purchase THREE Éternel →Ambassador Disclosure: Ed Drost is a compensated THREE International Founding Member and Brand Ambassador. This article contains affiliate links. All scientific claims are independently cited from primary sources. Not evaluated by the FDA. THREE International products are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult your physician before beginning a new supplement regimen.